Nicole Mowad-Nassar
Fortune : 186 558 $ au 31/08/2026
Fortune : 186 558 $ au 31/08/2026
Nicole Mowad-Nassar is currently an Independent Non-Executive Director at ResMed, Inc. since 2025 and Vice President-Marketing at Takeda Pharmaceuticals U.S.A., Inc. Formerly, Ms. Mowad-Nassar was Senior Vice President & President-Specialty at AbbVie, Inc. from 2023 to 2025.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/09/2026 | 777 ( 0% ) | 186 558 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| RESMED, INC. | Directeur/Membre du Conseil | 15/08/2025 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Sales & Marketing | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/09/2025 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
ResMed, Inc.
ResMed, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets devices for evaluation and treatment of sleep disorders | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national